Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Graham Holdings Company Common Stock (GHC) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance

Graham Holdings Company Common StockTrade
Kymera Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Graham Holdings Company Common Stock vs Kymera Therapeutics Inc. Common Stock — how do they compare? Graham Holdings Company Common Stock trades at $1,186.01 (market cap $4.97B), while Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B). The key difference: Kymera Therapeutics Inc. Common Stock is the larger of the two by market cap, and Graham Holdings Company Common Stock pays a 0.64% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Graham Holdings Company Common Stock for 0 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.

GHCKYMR
Market Cap
$4.97B$8.87B
Volume
27,383779,107
Sector
IndustrialsHealth
52-Week High
$1.23K$127.31
52-Week Low
$949.84$55.80
Typical Hold Time
0 Days0 Days
Enterprise Value
$5.06B$8.26B
Dividend Yield
0.64%—

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GHC
100% Buy0% Sell
Avg holding period · 0 Days
KYMR
100% Buy0% Sell
Avg holding period · 0 Days

About Graham Holdings Company Common Stock

Graham Holdings Company is a diversified holding company with operations spanning education services (Kaplan), television broadcasting (Graham Media Group), healthcare services, and manufacturing, among other businesses; it was formerly known as The Washington Post Company.

Read more on GHC →

About Kymera Therapeutics Inc. Common Stock

Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.

Read more on KYMR →